The benefits of HRT that are firmly established are symptom relief and bone protection. It is the most effective treatment available for hot flashes and night sweats, it prevents the accelerated bone loss that follows menopause, and it resolves vaginal and urinary symptoms that nothing else touches as well. Beyond that sit several probable benefits with weaker evidence, and a few claims that get repeated as fact but are not.

Sorting those tiers is the useful thing, because "HRT has benefits" and "HRT prevents dementia" are not statements with the same backing. Below is each benefit graded by evidence strength, the absolute numbers on risk, and what changes once you are past 60.

Benefits sorted by evidence strength

Benefit Evidence What is actually known
Hot flashes and night sweats Established The most effective treatment available. Relief usually within weeks
Vaginal dryness, painful sex, urinary symptoms Established Systemic or local estrogen both work. Local carries no systemic risk
Preventing osteoporosis and fractures Established A trial of over 25,000 postmenopausal women aged 50 to 79 found hormone therapy reduced fracture risk
Sleep quality Established, mostly indirect Improves largely by removing the night sweats waking you
Mood and irritability in menopause Probable Helps mood tied to hormonal change. Not a treatment for clinical depression
Muscle strength Probable Can help maintain strength alongside exercise, not instead of it
All-cause mortality when started early Probable 2024 WHI follow-up found lower all-cause mortality when started under 60 or within 10 years of the final period
Type 2 diabetes Probable, small Does not increase risk, and some studies suggest a slight reduction
Brain fog and concentration Mixed Commonly reported to improve. Trial evidence is inconsistent
Coronary heart disease Mixed Little or no effect overall, though timing changes the picture
Dementia and Alzheimer's prevention Not established Some studies suggest reduced risk, others do not. Not a reason to start
Bowel cancer, osteoarthritis Not established Signals in some research, nothing conclusive
Weight loss Not established Not a weight-loss treatment

Symptom relief, the benefit nothing else matches

Systemic estrogen is the most effective treatment there is for vasomotor symptoms. Not the most effective hormonal option, the most effective full stop. Non-hormonal alternatives exist and some work reasonably well, but none match it.

The sequence matters if you are judging whether it is working:

  • Hot flashes and night sweats: noticeably better in a few weeks, often four to six, with the fuller effect by about 12 weeks
  • Sleep: improves alongside the night sweats, usually within weeks
  • Mood, anxiety, concentration: slower, commonly one to three months
  • Vaginal dryness and urinary symptoms: the slowest, sometimes several months to fully settle

If nothing has shifted after three months on a steady dose, that usually means the dose needs adjusting rather than that hormones do not work for you. Our timeline guide covers the full sequence.

Bone protection

Estrogen loss drives rapid bone loss in the years right after menopause, and HRT prevents it. This is one of the few benefits with a formal approved indication behind it rather than just symptom control.

It matters most for people who reach menopause early. If your periods stopped before 45, bone protection is a primary reason to take hormones rather than a bonus, because you are facing an extra decade or more of low estrogen. Some evidence suggests HRT can partly reverse bone loss that has already happened, not merely halt it.

Bone benefit accrues while you take it and fades after you stop, which is why it is not a "five years and done" intervention for someone whose main concern is fracture risk.

What the 2024 WHI follow-up changed

Most of the fear around HRT traces to one trial. The Women's Health Initiative enrolled more than 16,000 women with a uterus, aged 50 to 79, average age 63, onto estrogen plus progesterone, and about 11,000 who had had a hysterectomy onto estrogen alone. The combined arm was stopped early in 2002, the estrogen-only arm in 2004. The headlines said hormones cause breast cancer and heart disease, and prescribing collapsed.

Two things about that trial are now clear. The average participant was 63 and more than a decade past menopause, which is not who HRT is typically prescribed to. And the long-term outcomes were not what the 2002 headlines implied.

In May 2024, WHI researchers published 20-year follow-up data showing no increase in deaths from breast cancer or cardiovascular disease among trial participants. The same follow-up found a decrease in all-cause mortality when hormone therapy was started under age 60 or within 10 years of the final period.

On breast cancer specifically, the WHI combined arm produced about eight cases per 10,000 women per year. The estrogen-only arm showed a decrease in breast cancer rates. For context, obesity, a sedentary lifestyle, and alcohol each carry greater breast cancer risk than hormone therapy does.

The practical consequence is that only a small minority of women who are candidates for HRT actually take it, largely out of fear built on a misread of one trial in an older population. Our page on HRT and cancer risk goes through the numbers in detail.

The risks, in absolute numbers

Benefits only mean something next to the risks, and relative risk percentages make small numbers sound enormous. Here they are as counts.

Risk Absolute figure Route dependence
Breast cancer About 5 extra cases per 1,000 women taking combined HRT for 5 years Little or no increase with estrogen-only
Blood clots Low, and raised by tablets Patches, gels and sprays do not raise clot risk
Stroke Slightly raised by tablets, still low under 60 Not raised by patches, gel or spray
Coronary heart disease Little or no effect Timing of initiation matters more than route

Two things follow from that table. Breast cancer risk rises with duration and age and falls again after you stop, and it is driven mainly by the progestogen component, which is why estrogen-only therapy after hysterectomy looks different. And route choice does real work: if you carry clot risk, transdermal estrogen sidesteps most of it, because it skips the liver first pass that raises clotting factors. Our patch comparison covers that route.

Vaginal estrogen sits outside this table entirely. The dose is low, almost nothing reaches the bloodstream, and it does not carry increased risk of breast cancer or clots.

Benefits of HRT after 60 and after 65

This is where general guides go quiet, and it is a genuinely different question depending on whether you are continuing or starting.

If you are already on HRT and doing well, turning 60 or 65 is not a reason to stop. The old "five years maximum" rule came from the misread WHI data and has been dropped. Current practice has moved from "lowest dose for the shortest time" toward the appropriate dose for the appropriate length of time. What you get is an annual review, not automatic withdrawal. Symptom relief and bone protection continue as long as you take it.

If you are starting fresh after 60, the arithmetic is different. Beyond 60, or more than 10 years past menopause, initiation is not the default, because cardiovascular and stroke risk have shifted. It is still possible with proper risk assessment, and if it goes ahead, a low transdermal dose is preferred over tablets.

After 65, two benefits remain reliably available to nearly everyone. Local vaginal estrogen, which has no meaningful systemic absorption and treats symptoms that typically worsen rather than improve with age. And continued systemic therapy if you are already established on it and still benefiting.

What is not a good reason to start at 68: preventing dementia or heart disease. The evidence does not support starting hormones for either. See our guide on when to start HRT for how the window works.

Skin, hair, and the wellness claims

Estrogen receptors sit in skin, hair follicles, joints, and the brain, which is why people report changes well beyond hot flashes: easier joints, less itchy skin, thicker hair, more energy. These reports are consistent and plausible, since estrogen affects skin collagen and hydration and the hair growth cycle. They are also not what HRT is prescribed for, and they are not well quantified in trials.

Does HRT make you more attractive? There is no evidence for that framing, and no study measures it. What is documented is that some people notice better skin hydration, less hair thinning, and reduced joint aches. Treat that as a welcome side effect rather than a reason to start. Our page on HRT and hair loss covers what the hair evidence supports.

On celebrities and HRT: a number of public figures, Oprah Winfrey among them, have spoken openly about their menopause experience in recent years, and that visibility has done real good in getting people to raise symptoms with a clinician at all. What it cannot tell you is whether HRT suits your history. Success stories are selected by definition, and the person telling you theirs does not know your clot risk or family history.

Who the benefits do not outweigh the risks for

  • Current or past breast cancer or another estrogen-sensitive cancer
  • Previous blood clot, stroke, or heart attack
  • Active liver disease
  • Unexplained vaginal bleeding, until it has been investigated
  • Untreated endometrial hyperplasia

If systemic hormones are ruled out, that does not mean nothing helps. Local vaginal estrogen is often still appropriate even where systemic therapy is not, and there are non-hormonal options worth working through with a clinician.

What to do next

If you are under 60 with symptoms and no contraindications, the benefits most likely outweigh the risks, and the conversation is about route and dose rather than whether. If you are past 60 and already on it and doing well, the reasonable ask at your next review is to continue, not to justify continuing. If you are past 60 and considering starting, ask specifically about transdermal delivery and about vaginal estrogen for local symptoms.

Frequently Asked Questions

What are the main benefits of HRT?

Relief of hot flashes, night sweats, sleep disruption, and vaginal and urinary symptoms, plus prevention of osteoporosis. Those are the established ones. Mood, muscle strength, and lower all-cause mortality when started early are probable.

Do the benefits of HRT outweigh the risks?

For most people under 60 with menopause symptoms and no high risk of breast cancer or clots, yes. That is the standard position. Past 60, or with a relevant history, it becomes an individual calculation.

Are there benefits to taking HRT after 65?

Yes, if you are already on it and benefiting: symptom control and bone protection continue, and there is no age at which it must be stopped. Local vaginal estrogen is appropriate at any age. Starting systemic HRT for the first time after 65 is a different and more cautious conversation.

Does HRT reduce the risk of dementia?

Not established. Some studies suggest a reduced risk, particularly when started during perimenopause, and others find no effect. It is not currently a reason to start hormone therapy.

Does HRT help you lose weight?

No, it is not a weight-loss treatment. Some people find it easier to manage weight once sleep and energy improve, and fluid retention early on can look like weight gain. Our page on HRT and weight gain covers what happens.

Is HRT safer as a patch than a tablet?

For clots and stroke, yes. Patches, gels and sprays deliver estrogen through the skin and do not raise clot risk the way tablets can, because they bypass the liver first pass. For breast cancer risk, the progestogen component and duration matter more than the route.

Sources